QSI Stock Overview
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS).
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Quantum-Si incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.61 |
| 52 Week High | US$3.90 |
| 52 Week Low | US$1.12 |
| Beta | 3.07 |
| 1 Month Change | -9.04% |
| 3 Month Change | -2.42% |
| 1 Year Change | 9.52% |
| 3 Year Change | -84.50% |
| 5 Year Change | n/a |
| Change since IPO | -83.70% |
Recent News & Updates
Recent updates
Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans
Apr 19
Quantum-Si: Commercial Lift Imminent
Feb 05Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth
Dec 04We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth
Jun 28Jeff Hawkins is the new CEO of Quantum-Si
Oct 04Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform
Sep 24Quantum-Si: Merging Semiconductors With Biology Will Scale Things Fast
Jul 30Proteomics May Be The Future Of Biotech, Quantum-Si Is A Potential Leader
Jul 11Shareholder Returns
| QSI | US Life Sciences | US Market | |
|---|---|---|---|
| 7D | 6.6% | 3.6% | 1.0% |
| 1Y | 9.5% | 3.2% | 21.9% |
Return vs Industry: QSI exceeded the US Life Sciences industry which returned 4.7% over the past year.
Return vs Market: QSI underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| QSI volatility | |
|---|---|
| QSI Average Weekly Movement | 14.9% |
| Life Sciences Industry Average Movement | 6.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: QSI's share price has been volatile over the past 3 months.
Volatility Over Time: QSI's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 159 | Jeff Hawkins | www.quantum-si.com |
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company’s platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications.
Quantum-Si incorporated Fundamentals Summary
| QSI fundamental statistics | |
|---|---|
| Market cap | US$228.25m |
| Earnings (TTM) | -US$95.96m |
| Revenue (TTM) | US$1.08m |
211.0x
P/S Ratio-2.4x
P/E RatioIs QSI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QSI income statement (TTM) | |
|---|---|
| Revenue | US$1.08m |
| Cost of Revenue | US$594.00k |
| Gross Profit | US$488.00k |
| Other Expenses | US$96.45m |
| Earnings | -US$95.96m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 09, 2024
| Earnings per share (EPS) | -0.68 |
| Gross Margin | 45.10% |
| Net Profit Margin | -8,868.76% |
| Debt/Equity Ratio | 0% |
How did QSI perform over the long term?
See historical performance and comparison